Kahlert S - Search Results

1

[Metastatic breast cancer--surgical possibilities].

Bauerfeind I, Kahlert S, Löhrs B, Heinemann V, Schaffer P, Hoffmann RT, Loeff G, Löhe F. Bauerfeind I, et al. Among authors: kahlert s. MMW Fortschr Med. 2008 Jan 17;150(1-2):37-9. doi: 10.1007/BF03365277. MMW Fortschr Med. 2008. PMID: 18300642 Review. German. No abstract available.

2

[Multimodality treatment concepts for metastatic breast cancer].

Heinemann V, Kahlert S, Stemmler HJ. Heinemann V, et al. Among authors: kahlert s. Internist (Berl). 2010 Nov;51(11):1358-65. doi: 10.1007/s00108-010-2676-4. Internist (Berl). 2010. PMID: 21107788 Review. German.

3

[Neoadjuvant therapy of breast cancer].

Rühl I, Bauerfeind I, Kahlert S, Untch M, Hepp H. Rühl I, et al. Among authors: kahlert s. Gynakol Geburtshilfliche Rundsch. 2004 Apr;44(2):92-101. doi: 10.1159/000076862. Gynakol Geburtshilfliche Rundsch. 2004. PMID: 15073438 Review. German.

4

[Breast cancer treatment during pregnancy - experiences in the department of OB/GYN Grosshadern-Munich and review of international data].

Kahlert S, Bauerfeind I, Strauss A, Untch M. Kahlert S, et al. Zentralbl Gynakol. 2004 Jun;126(3):159-66. doi: 10.1055/s-2004-822693. Zentralbl Gynakol. 2004. PMID: 15236101 German.

5

Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.

Stemmler HJ, Kahlert S, Siekiera W, Untch M, Heinrich B, Heinemann V. Stemmler HJ, et al. Among authors: kahlert s. Breast. 2006 Apr;15(2):219-25. doi: 10.1016/j.breast.2005.04.017. Epub 2005 Jul 18. Breast. 2006. PMID: 16026983

6

High efficacy of gemcitabine and cisplatin plus trastuzumab in patients with HER2-overexpressing metastatic breast cancer: a phase II study.

Stemmler HJ, Kahlert S, Brudler O, Beha M, Müller S, Stauch B, Heinemann V. Stemmler HJ, et al. Among authors: kahlert s. Clin Oncol (R Coll Radiol). 2005 Dec;17(8):630-5. doi: 10.1016/j.clon.2005.06.010. Clin Oncol (R Coll Radiol). 2005. PMID: 16372489 Clinical Trial.

7

Lasting remission following multimodal treatment in a patient with metastatic breast cancer.

Stemmler HJ, Menzel H, Salat C, Lindhofer H, Kahlert S, Heinemann V, Kolb HJ. Stemmler HJ, et al. Among authors: kahlert s. Anticancer Drugs. 2005 Nov;16(10):1135-7. doi: 10.1097/01.cad.0000180122.24031.13. Anticancer Drugs. 2005. PMID: 16222157

8

Dose-dense intensified sequential versus conventionally-dosed anthracycline and taxane-containing neoadjuvant therapy in patients with inflammatory breast cancer.

Ditsch N, Vodermaier A, Hinke A, Burghardt S, Lenhard M, Löhrs B, Toth B, Von Koch F, Kahlert S, Bauerfeind I, Konecny GE, Loibl S, VON Minckwitz G, Untch M. Ditsch N, et al. Among authors: kahlert s. Anticancer Res. 2012 Aug;32(8):3539-45. Anticancer Res. 2012. PMID: 22843943 Clinical Trial.

9

Chemosensitivity testing in gynecologic oncology--dream or reality?

Untch M, Ditsch N, Langer E, Kurbacher C, Crohns C, Konecny G, Kahlert S, Bauerfeind I, Hepp H. Untch M, et al. Among authors: kahlert s. Recent Results Cancer Res. 2003;161:146-58. doi: 10.1007/978-3-642-19022-3_13. Recent Results Cancer Res. 2003. PMID: 12528806 Review.

10

Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.

Stemmler HJ, Salat C, Lindhofer H, Menzel H, Untch M, Kahlert S, Konecny G, Sauer H, Ledderose G, Heinemann V, Kolb HJ. Stemmler HJ, et al. Among authors: kahlert s. Anticancer Res. 2005 Jul-Aug;25(4):3047-54. Anticancer Res. 2005. PMID: 16080564 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters